Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05713864 · ClinicalTrials.gov registry record · NA
Combination Treatment With BTL-899 and HPM-6000UF Devices II
A NA study, sponsored by BTL Industries.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
NCT05713864 is a NA study that has completed, run by BTL Industries. The registered enrollment target is 33 participants.
The verdict
NCT05713864, a NA study, has completed, sponsored by BTL Industries.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
Study Summary
This study will evaluate the clinical efficacy of the BTL-899 and HPM-6000UF devices in combination for non-invasive strengthening of the core muscles and overall improvement in quality of life in female patients after childbirth.
Interventions
- DEVICE BTL-899
- DEVICE HPM-6000UF
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2022-03-08 |
| Est. Completion | 2022-11-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05713864
The ClinicalTrials.gov registry entry for NCT05713864 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is BTL Industries, which has 40 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which BTL-899 is the first listed.
NCT05713864 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05713864 about?
NCT05713864 is a clinical study titled "Combination Treatment With BTL-899 and HPM-6000UF Devices II". This study will evaluate the clinical efficacy of the BTL-899 and HPM-6000UF devices in combination for non-invasive strengthening of the core muscles and overall improvement in quality of life in female patients after childbirth.
What is the current status of trial NCT05713864?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2022-03-08. Estimated completion is 2022-11-30.
What interventions are being tested in trial NCT05713864?
The interventions under investigation include: BTL-899 (DEVICE), HPM-6000UF (DEVICE).
Who is sponsoring clinical trial NCT05713864?
This trial is sponsored by BTL Industries, which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.